Accumulating evidence demonstrates that the expression of SNHG3 was increased in variety types of tumor tissues such as breast cancer, hepatocellular carcinoma, and colorectal cancer, resulting in increased proliferation and metastasis of tumor cells and poor survival of tumor-bearing patients [10–13]. Here, SNHG3 is linked to breast carcinoma.